EGFL7 anticorps (AA 30-80) (HRP)
Aperçu rapide pour EGFL7 anticorps (AA 30-80) (HRP) (ABIN733997)
Antigène
Voir toutes EGFL7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 30-80
-
Homologie
- Human,Mouse,Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from mouse EGFL7
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:100-1000
IHC-P 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- Gentamicin sulfate
-
Précaution d'utilisation
- This product contains Gentamicin sulfate: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
-
Autre désignation
- Egfl7
-
Sujet
-
Synonyms: Zneu1, VE-statin, Epidermal growth factor-like protein 7, EGF-like protein 7, Multiple epidermal growth factor-like domains protein 7, Multiple EGF-like domains protein 7, NOTCH4-like protein, Vascular endothelial statin, Egfl7, Megf7
Background: Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cell adhesion to the extracellular matrix and angiogenesis.
-
ID gène
- 353156
-
UniProt
- Q9QXT5
Antigène
-